MarketTrends2023

Cannabidiol Market As per Cannabidiol Market analysts, the global market is anticipated to witness growth owing to the factors such as the growing research & development as well as financial support by various private and government organizations. However, the market will face challenges and restraints due to adverse effects associated with cannabis and stringent government policies during the forecast period. The cannabidiol market size was valued USD 18.43 billion in 2022 and is expected to reach USD 59.43 Billion by 2030 at 18.2% CAGR during the forecast period 2022-2030. Rising occurrence of chronic diseases in the Cannabidiol Market will support the growth. As per market analysts, the market-based companies will face certain challenges during the forecast period 2019 to 2026. The market research report provides in-depth analysis of the application, end user, forms, product, routes of administration, and source segments. The market research report presents factors su...

Healthcare Artificial Intelligence (AI) Market T he healthcare artificial intelligence market is expected to reach USD 12.22 Billion at of 51.9% CAGR during the forecast period 2022-2030 . The growing desire to reduce healthcare expenses, as well as increases in processing power and lower hardware costs, boost the healthcare artificial intelligence market. An increase in the number of collaborations and partnerships between various domains in the healthcare ecosystem, as well as a greater need to improve the quality of healthcare services as a result of the disconnect between patients and health workers. Artificial intelligence allows doctors to use tools that help them diagnose and treat patients more accurately and quickly. However, doctors are hesitant to embrace modern technology, despite patients' increasing preference for them over in-person therapy. With this issue posing a threat to the doctor-patient connection and doctors' reluctance to use AI technology, the...

EClinical Solutions Market The eClinical Solutions Market is projected to record a CAGR of 12% to influence earnings of USD 14.36 billion by 2030. Clinical trials are increasingly growing complex, and there has been a massive increase in the amount of clinical data generated which calls for proper management. eClinical solutions are gaining momentum among pharmaceutical and biotechnology companies are progressively leveraging eClinical solutions to manage the huge volume of data.   The risks and costs associated with clinical trials continue to surge which puts enormous pressure on enterprises to optimize ROI in new drug development. eClinical solutions assist in automating and streamlining processes and thereby minimizes drug development costs. Clinical research organizations (CRO) pharmaceutical companies are the primary end users for eClinical solutions and growth in the number of CROs is stimulating the growth of the global eClinical solutions market. Other driv...

  Bioelectric Medicine Market The bioelectric medicine market can anticipate reaching USD 31.65 billion by 2030 while attaining a 6.46% CAGR from 2022 to 2030, reveals Market Research Future (MRFR). Bioelectric medicine, also known as electroceuticals, is an emerging field in healthcare that aims to treat various medical conditions using electrical impulses. These electrical impulses are delivered through implantable devices or non-invasive methods, such as transcutaneous electrical nerve stimulation (TENS) or transcranial magnetic stimulation (TMS). Primary Boosters and Restraints By combining bioengineering, molecular medicine, and neurology, bioelectric medicine creates nerve-stimulating devices for the control of biological processes during disease treatment. The main factor projected to drive the market is the increased prevalence of chronic diseases like cardiac and neurological problems. According to the CDC, over 610 thousand Americans per year pass away from car...

Thalassemia Treatment Market Thalassemia is an inherited blood disorder that is characterized by inadequate hemoglobin and fewer red blood cells in the body than normal. Hemoglobin is the substance in red blood cells that allows them to carry oxygen. The inadequate hemoglobin and fewer red blood cells of thalassemia may cause anemia. According to MRFR analysis,  Thalassemia Treatment Market   is expected to register a Moderate CAGR  during the forecast period. The growth of the Global Thalassemia Treatment Market is driven by various factors such as rising incidence of thalassemia, increasing pipeline drugs in thalassemia, rise in awareness regarding available treatment options for the treatment of thalassemia, growing public awareness related to preventive care and rise in demand for improved curative gene therapy. However, stringent regulatory policies and high treatment costs are expected to curb the growth of the global thalassemia treatment market. The ...

  Body Composition Analyzers Market The Body Composition Analyzers Market is expected to reach USD 670.48 Million by 2030 at 8.10% CAGR during the forecast period 2022-2030. Body composition contains three major compound water, fat mass, and muscle mass. Body composition analyzing devices are used for measuring the ratio of water, fat, and muscles in the body and recording their respective values at the point of the investigation. Body composition analyzers provide aid in analysis of increased variations in the body structure for a specific period. It has applications medical research, sports, causal association research studies in the disciplines of nutrition, anthropology, epidemiology, etc. The growth of the global body composition analyzers market is determined by numerous factors such as increasing prevalence of metabolic disorders, technological advancements in the healthcare industry, and rising obese population. However, the increasing cost of body composition anal...

Gene Therapy Market Gene Therapy Marke t is expected to rise at a CAGR of 19.10%, with a value of USD 3.22 billion by 2030. The gene therapy market refers to the development and commercialization of therapeutic products that use genetic material to treat or prevent diseases. Gene therapy involves the introduction of genetic material, such as DNA or RNA, into cells to correct or modify their function. The goal of gene therapy is to treat the underlying genetic cause of a disease, rather than just managing its symptoms. The global gene therapy market has been growing rapidly in recent years, driven by advances in gene editing technologies, an increasing understanding of genetic diseases, and the potential for gene therapy to provide a one-time cure for certain diseases. Gene therapy involves therapies that target the genetic root cause of a disease and eradicate the disease at this base level. The system is focused on the use of introduced nucleic acids as an alternative to dru...